MetaCap

Black Hawk Acquisition (BKHA) vs Senti Biosciences (SNTI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Black Hawk Acquisition is the larger company by market cap ($7.7 million vs $4.6 million), about 1.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BKHA-85.77%SNTI+436.36%
+787%+330%-127%
Oct 7, 20261 yearNov 20, 2026
BKHA-83.95%SNTI+462.98%
+490%+190%-111%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BKHA versus SNTI key metrics
MetricBKHASNTI
Share price$1.85$1.77
Market cap$7.68M$4.60M
1-day change-71.45%-36.56%
YTD return—+70.19%
1-year return—-8.76%
5-year return—-98.23%
P/E ratio (TTM)5.61—
EPS (TTM)$0.33$-46.20
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$22.00K
Net income (latest FY)$1.33M$-61.44M
Operating margin—-312631.82%
Net margin—-279263.64%
52-week high$23.00$95.04
52-week low$1.75$1.71
Distance from 52-week high-91.96%-98.14%
Analyst consensus—none
Avg. price target upside—+662.71%
Average volume101.40K108.98K
Shares outstanding4.15M2.60M
Employees—39
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Black Hawk Acquisition

BKHA stock →

Black Hawk Acquisition Corporation is a blank check company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2023 and is based in Danville, California.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances)

About Senti Biosciences

SNTI stock →

Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 39 employees

BKHA vs SNTI FAQ

Which is bigger, Black Hawk Acquisition or Senti Biosciences?

Black Hawk Acquisition (BKHA) is larger, with a market capitalization of $7.68M compared with $4.60M for Senti Biosciences (SNTI).

Are Black Hawk Acquisition and Senti Biosciences in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons